相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Su1140 Screening for Opportunistic Infections Prior to Anti-TNF Therapy in Crohn's Disease Does Not Preclude the Occurrence of Serious Infections
Tim D. Belderbos et al.
GASTROENTEROLOGY (2015)
Efficacy of Hepatitis B Vaccination and Revaccination and Factors Impacting on Response in Patients With Inflammatory Bowel Disease
J. P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Performance of interferon-gamma release assays in patients with inflammatory bowel disease: A systematic review and meta-analysis
Neal Shahidi et al.
INFLAMMATORY BOWEL DISEASES (2012)
UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS
Siok Swan Tan et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2012)
Hepatitis B Virus Screening Before Chemotherapy for Lymphoma: A Cost-Effectiveness Analysis
Urszula Zurawska et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
J. J. Ott et al.
VACCINE (2012)
COST ANALYSIS OF SCREENING ACCORDING TO ECCO GUIDELINES FOR PREVENTION OF OPPORTUNISTIC INFECTIONS IN INFLIXIMAB-TREATED IBD PATIENTS
A. Metz et al.
GUT (2011)
Guidelines for the management of inflammatory bowel disease in adults
Craig Mowat et al.
GUT (2011)
Prednisolone Treatment Affects the Performance of the QuantiFERON Gold In-Tube Test and the Tuberculin Skin Test in Patients with Autoimmune Disorders Screened for Latent Tuberculosis Infection
Erika Belard et al.
INFLAMMATORY BOWEL DISEASES (2011)
QuantiFERON TB Gold Testing for Tuberculosis Screening in an Inflammatory Bowel Disease Cohort in the United States
Bashar J. Qumseya et al.
INFLAMMATORY BOWEL DISEASES (2011)
Factors Impacting the Results of Interferon-gamma Release Assay and Tuberculin Skin Test in Routine Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Diseases
Pavol Papay et al.
INFLAMMATORY BOWEL DISEASES (2011)
Cost-Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Solid Tumors
Fiona L. Day et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient
Sharmeel K. Wasan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
Asher Kornbluth et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
C. Loras et al.
GUT (2010)
Prevalence of Hepatitis B and C and Risk Factors for Nonvaccination in Inflammatory Bowel Disease Patients in Northeast France
Jean-Baptiste Chevaux et al.
INFLAMMATORY BOWEL DISEASES (2010)
Overall and Cause-Specific Mortality in Crohn's Disease: A Meta-analysis of Population-Based Studies
Dana Duricova et al.
INFLAMMATORY BOWEL DISEASES (2010)
Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study
Carme Loras et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2009)
Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn's disease - modelling outcomes in active luminal and fistulizing disease in adults
J. Lindsay et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Comparison of Interferon-Gamma Release Assay Versus Tuberculin Skin Test for Tuberculosis Screening in Inflammatory Bowel Disease
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update
Madhukar Pai et al.
ANNALS OF INTERNAL MEDICINE (2008)
Health State Utilities in Latent and Active Tuberculosis
Na Guo et al.
VALUE IN HEALTH (2008)
The impact of chronic hepatitis B on quality of life: A multinational study of utilities from infected and uninfected persons
Adrian R. Levy et al.
VALUE IN HEALTH (2008)
Short-term outcomes after laparoscopic ileocolic resection for Crohn's disease
Sebastiaan W. Polle et al.
DIGESTIVE SURGERY (2006)
American thoracic society/centers for disease control and prevention/infectious diseases society of America: Controlling tuberculosis in the United States
CM Nolan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study
S Bargiggia et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
J Askling et al.
ARTHRITIS AND RHEUMATISM (2005)
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
L Carmona et al.
ARTHRITIS AND RHEUMATISM (2005)
Impairment of health-related quality of life in patients with inflammatory bowel disease:: A Spanish multicenter study
F Casellas et al.
INFLAMMATORY BOWEL DISEASES (2005)
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2004)
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis
M Esteve et al.
GUT (2004)
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report
JJ Gómez-Reino et al.
ARTHRITIS AND RHEUMATISM (2003)
Epidemiology of hepatitis B in Europe and worldwide
MJ Alter
JOURNAL OF HEPATOLOGY (2003)
Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States
K Khan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
European framework for tuberculosis control and elimination in countries with a low incidence - Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) working group
JF Broekmans et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Hepatitis B and C virus infection in Crohn's disease
L Biancone et al.
INFLAMMATORY BOWEL DISEASES (2001)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
